Contraceptive Patch | Shim Clinic, Singapore

Share |

Summary

Contraceptive Patch | Shim Clinic, Singapore: Ortho Evra® transdermal contraceptive patch clinic, Singapore. Hormonal contraceptive, for birth control and contraception. Definitions, references, and latest news.

Description

Evra® trandermal contraceptive patch is an innovative method of drug delivery for those who prefer not to take oral contraceptives. The first patch is applied on the first day of menstruation. Just one patch is applied per week for the first three weeks. This is followed by one patch free week. References

• Contraceptive patch - Wikipedia, the free encyclopedia
• Contraceptive patch: Definition from Answers.com
• Contraceptive patch - definition of Contraceptive patch in the Medical dictionary - by the Free Online Medical Dictionary, Thesaurus and Encyclopedia.
• Evra® package insert

Agile completes Phase III study of hormonal contraceptive patch
Tue, 03 Jan 2012 00:00:00 +0100 | Drug Development Technology
Agile Therapeutics has concluded the final Phase III clinical trial of AG200-15, the company's hormonal contraceptive patch containing ethinyl estradiol in combination with levonorgestrel. (Source: Drug Development Technology)

FDA Panel: Ortho Evra Benefits Outweigh Risks
Sun, 01 Jan 2012 05:00:00 +0100 | Ob.Gyn. News
ADELPHI, MD. – Advisors to the Food and Drug Administration voted 19-5 that the benefits of the Ortho Evra contraceptive patch outweighed its risks, although they agreed with epidemiologic evidence that use of the patch is associated with an increased risk of venous thromboembolic events. (Source: Ob.Gyn. News)

More Teen Males Using Condoms When They First Have Sex: Survey
Wed, 12 Oct 2011 04:00:00 +0100 | Pediatrics News - Doctors Lounge
And more females are turning to contraceptive patch, emergency contraception (Source: Pediatrics News - Doctors Lounge)

Transdermal Contraception as a Model for Adolescent Use of New Methods
Wed, 25 May 2011 04:00:00 +0100 | Journal of Adolescent Health
Conclusions: This model provides a framework for understanding the use of new contraceptive methods and can inform clinical strategies for contraceptive counseling with adolescents. (Source: Journal of Adolescent Health)

Agile Therapeutics AG200-15 Contraceptive Patch Shows Hormonal Exposure Similar To Low-Dose Oral Contraceptives In Phase II Data
Tue, 03 May 2011 15:00:00 +0100 | Health News from Medical News Today
Agile Therapeutics, a pharmaceutical company focused on developing and commercializing more convenient women's contraceptive products, today announced the presentation and publication of three studies highlighting Phase II data with AG200-15, the company's combination hormonal contraceptive patch. The definitive pharmacokinetic study demonstrated that AG200-15 delivers a daily estrogen (ethinyl estradiol) dose of 30ug, comparable to low-dose oral contraceptives... (Source: Health News from Medical News Today)

Adolescents’ Experiences Using the Contraceptive Patch versus -----
Wed, 30 Mar 2011 23:00:00 +0100 | Journal of Pediatric and Adolescent Gynecology
Conclusions: Despite apparent advantages of the patch over the ----, adolescents using both methods continue to face challenges achieving perfect and sustained contraceptive use. (Source: Journal of Pediatric and Adolescent Gynecology)

DVT risk with injectable depot medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device
Thu, 28 Oct 2010 23:00:00 +0100 | NeLM - News
This study performed within the Multiple Environmental and Genetic Assessment of risk factors for venous thrombosis (MEGA) study, a large population-based case-control study on risk factors for venous thrombosis, examined the venous thrombotic risk associated with non-oral hormonal contraceptives (injectable depot-medroxyprogesterone acetate (DMPA) Ccontraceptives, hormone [levonorgestrel]-releasing intrauterine (LNG IUD) devices, a contraceptive patch, or a contraceptive implant).   The current analyses included premenopausal women (446 patients and 1146 controls [no history DVT]) aged 18 to 50 years, who ... (Source: NeLM - News)

Agile Therapeutics Announces Study Results Demonstrating Contraceptive Patch AG200-15 Delivers A Low Dose Of Estrogen
Tue, 26 Oct 2010 11:30:00 +0100 | Pharmaceutical Online News
Agile Therapeutics announced results today from a Phase 2 clinical study of AG200-15, Agile's weekly contraceptive patch containing ethinyl estradiol (EE) in combination with levonorgestrel (LNG). (Source: Pharmaceutical Online News)

Contraception choices in women with underlying medical conditions.
Tue, 14 Sep 2010 23:00:00 +0100 | American Family Physician
Authors: Bonnema RA, McNamara MC, Spencer AL Primary care physicians often prescribe contraceptives to women of reproductive age with comorbidities. Novel delivery systems (e.g., contraceptive patch, contraceptive ring, single-rod implantable device) may change traditional risk and benefit profiles in women with comorbidities. Effective contraceptive counseling requires an understanding of a woman's preferences and medical history, as well as the risks, benefits, adverse effects, and contraindications of each method. Noncontraceptive benefits of combined hormonal contraceptives, such as oral contraceptive -----, include regulated menses, decreased dysmenorrhea, and diminished premenstrual dysphoric disorder. Oral contraceptive ----- may be used safely in women with a range of medical c...